Purple Biotech (PPBT) Net Equity Issued and Repurchased (2014 - 2015)
Purple Biotech's (PPBT) quarterly Net Equity Issued and Repurchased came in at $4.5 million in Q4 2015, up 136.68% quarter-over-quarter from $1.9 million in Q3 2014.
Powered by 
Analysis
Purple Biotech (PPBT) Net Equity Issued and Repurchased (2014 - 2015) Analysis & Trends
Purple Biotech (PPBT) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $4.5 million the latest figure, recorded in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.24 Bn | 192.25 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.01 Bn | 176.83 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.33 Bn | 123.47 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.87 Bn | 73.87 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 60.27 Bn | 55.08 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.93 Bn | 48.79 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.17 Bn | 29.86 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.89 Bn | 30.60 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.12 Bn | 29.12 Bn | 1.16 Mn | - |
| 10 | Purple Biotech | 282,022.44 | 282,022.44 | - | - |